Hybridomas are obtained by fusing normal B lymphocytes with a myeloma (tumor B cell line). Thus, a cloned hybridoma cell line has an unlimited capacity to grow in culture, producing immunoglobulin molecules with identical structure and antigen specificity, termed monoclonal antibodies (mAbs), which may have a wide variety of applications. We license 13 different hybridoma cell lines under the following conditions:
- Worldwide license
- Non-exclusive license
- An up-front payment
- Royalty on Sales
- Without any right to sublicense
Ref: TEC0072
